Cited by — Prognostic relevance of secondary actionable fusions in MLH1-deficient dMMR/MSI-H gastrointestinal tumors treated with pembrolizumab | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Prognostic relevance of secondary actionable fusions in MLH1-deficient dMMR/MSI-H gastrointestinal tumors treated with pembrolizumab.
No admitted local citation edges point to this work yet.
